Open
Source verified June 23, 2026
Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition
Supports Canadian-led lobular carcinoma research
Funding available
Varies by project
Deadline
Open continuously
Location
Canada
Overview
Breast Cancer Canada’s 2026 Lobular Carcinoma Research Grant Competition supports Canadian-led breast cancer research focused on precision oncology. It funds targeted diagnostics and targeted treatment projects, including screening, detection, follow-up, surgery, medicine, and radiation.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Increase social or community impact
- Conduct research and development activities
Eligible Funding
- Varies by project
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Canada
Legal structures
- All legal structures
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Precision oncology research in lobular carcinoma
- Targeted diagnostics, including screening, detection, and follow-up
- Targeted treatment, including surgery, medicine, and radiation
Documents Needed
- Letter of Intent
- Grant Proposal
Official resources
Eligibility
Who is eligible?
- Canadian research teams
- Canadian-led research projects
Selection criteria
- Strong focus on precision oncology
- Strong focus on AI-driven innovation
- Strong focus on patient partnership
How to apply
- Begin the Letter of Intent using the provided link.
- Submit the Letter of Intent by email to research@breastcancerprogress.ca.
- Submit the Grant Proposal by the stated deadline.
Processing and Agreement
- Letter of Invitation is issued by BCC after the LOI stage.
- Notice of Decision is issued by BCC on April 17, 2026.
Additional information
- Applications are accepted by email to research@breastcancerprogress.ca.
- Applicants may choose a core focus area and a budget category.
- The program has two grant tiers.
- Funding starts on June 30, 2026.
Frequently Asked Questions about the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition Program
What is the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition?
Breast Cancer Canada’s 2026 Lobular Carcinoma Research Grant Competition supports Canadian-led breast cancer research focused on precision oncology. It funds targeted diagnostics and targeted treatment projects, including screening, detection, follow-up, surgery, medicine, and radiation.
Who is eligible for the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition program?
To be eligible for the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition program, you must:
Canadian-led research projects only
Projects must involve active engagement from a breast cancer patient advocate
Projects should be grounded in science, data, and lived experience
What expenses are eligible under Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition?
Precision oncology research in lobular carcinoma
Targeted diagnostics, including screening, detection, and follow-up
Targeted treatment, including surgery, medicine, and radiation
Who can I contact for more information about the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition?
You can contact Breast Cancer Society of Canada (BCC).
Where is the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition available?
The Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition program is available across Canada.
Is the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition a grant, loan, or tax credit?
Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition is a Grant and Funding
Who are the financial supporters of the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition?
Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition is funded by Breast Cancer Society of Canada (BCC)